US HB5854 | 2013-2014 | 113th Congress
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on December 11 2014 - 25% progression, died in committee
Action: 2014-12-11 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on December 11 2014 - 25% progression, died in committee
Action: 2014-12-11 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Amends the Federal Food, Drug, and Cosmetic Act to declare that nothing in it or in the Public Health Service Act shall prevent or restrict, and the Food and Drug Administration (FDA) shall not implement or enforce any law to prevent or restrict, the importation, distribution, or sale of investigational drugs or devices for terminally ill patients.
Title
To allow the importation, distribution, and sale of investigational drugs and devices intended for use by terminally ill patients who execute an informed consent document.
Sponsors
| Rep. Alan Grayson [D-FL] |
History
| Date | Chamber | Action |
|---|---|---|
| 2014-12-11 | House | Referred to the House Committee on Energy and Commerce. |
Same As/Similar To
HB4475 (Related) 2014-04-11 - Referred to the Subcommittee on Health.
Subjects
Drug safety, medical device, and laboratory regulation
Drug therapy
Health
Health technology, devices, supplies
Long-term, rehabilitative, and terminal care
Prescription drugs
Retail and wholesale trades
Trade restrictions
Drug therapy
Health
Health technology, devices, supplies
Long-term, rehabilitative, and terminal care
Prescription drugs
Retail and wholesale trades
Trade restrictions
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/113th-congress/house-bill/5854/all-info |
| Text | https://www.congress.gov/113/bills/hr5854/BILLS-113hr5854ih.pdf |
